Page last updated: 2024-10-28

lidocaine and Thoracic Neoplasms

lidocaine has been researched along with Thoracic Neoplasms in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garzón-Rodríguez, C1
Casals Merchan, M1
Calsina-Berna, A1
López-Rómboli, E1
Porta-Sales, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Preventive Application Of Lidocaine Patch In Adjunction To Intravenous Morphine Analgesia For Management Of Post-Thoracotomy Pain: Results Of A Randomized, Double Blind, Placebo Controlled Study[NCT02751619]90 participants (Actual)Interventional2013-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for lidocaine and Thoracic Neoplasms

ArticleYear
Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:11

    Topics: Anesthetics, Local; Breast Neoplasms; Cicatrix; Female; Follow-Up Studies; Humans; Lidocaine; Male;

2013